DIN 02491087 — EMGALITY 120 MG
EMGALITY is a solution of Galcanezumab marketed by ELI LILLY CANADA INC. The full Galcanezumab monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02491087
- Brand name
- EMGALITY
- Active ingredient
- Galcanezumab
- Strength
- 120 MG
- Dosage form
- SOLUTION
- Route
- SUBCUTANEOUS
- Manufacturer
- ELI LILLY CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Calcitonin gene-related peptide (CGRP) monoclonal antibody
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Galcanezumab products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02505134 | EMGALITY | 100 MG | SOLUTION | ELI LILLY CANADA INC | MARKETED |
| 02491060 | EMGALITY | 120 MG | SOLUTION | ELI LILLY CANADA INC | MARKETED |